Course Lecture Videos
2021 Course Offering of Training in Neurotherapeutics Discovery and Development for Academic Scientists
Session 1: Target and Pathway Interrogation
James Inglese, PhD, National Center for Advancing Translational Sciences, NIH
James Inglese, PhD, National Center for Advancing Translational Sciences, NIH
Session 2: Biology Basics for Identifying Hits
William Janzen, BS, Epizyme, Inc.
William Janzen, BS, Epizyme, Inc.
Session 3: Moving from Hit to Lead to Clinical Candidate
James Barrow, PhD, Johns Hopkins School of Medicine
James Barrow, PhD, Johns Hopkins School of Medicine
Session 4: Antibody-Based Therapies
Gai Ayalon, PhD
Gai Ayalon, PhD
Session 6: Intellectual Property
Jeffrey W. Childers, PhD
Jeffrey W. Childers, PhD
Session 7: Alternative Approaches to Lead Generation
Sam J. Enna, PhD, The University of Kansas
Sam J. Enna, PhD, The University of Kansas
Session 8: ADME
Kennan Marsh, PhD, AbbVie
Kennan Marsh, PhD, AbbVie
Invited Guest Speaker: The Story of Risdiplam/Everysdi
Alexander Stephan, PhD, Roche Pharma Research
Alexander Stephan, PhD, Roche Pharma Research
Session 10: Rigor in Translational Drug Discovery and Development
Shai Silberberg, PhD, NIH/NINDS
Shai Silberberg, PhD, NIH/NINDS
Session 11: Toxicology
Adaline Smith, PhD, DABT, Ironwood Pharmaceuticals
Adaline Smith, PhD, DABT, Ironwood Pharmaceuticals
Session 12: IND Enabling Studies and Preparation of the IND
Edward Spack, PhD, Medared
Edward Spack, PhD, Medared
Session 13: Formulation and Route of Administration
James Cloyd III, PharmD, University of Minnesota
James Cloyd III, PharmD, University of Minnesota
Session 13: Formulation and Route of Administration
Maureen Donovan, PhD, University of Iowa
Maureen Donovan, PhD, University of Iowa
Session 13: Antisense Oglionucleotides
Gene Liau, PhD, Stoke Therapeutics
Gene Liau, PhD, Stoke Therapeutics
Session 14: Clinical Considerations in the Non-Clinical Phase of Drug Discovery and Development
James Vornov, MD, PhD, Johns Hopkins School of Medicine and Medpace
James Vornov, MD, PhD, Johns Hopkins School of Medicine and Medpace
Session 15: Funding Academic Drug Discovery Research
Charles L. Cywin, PhD, NIH/NINDS
Charles L. Cywin, PhD, NIH/NINDS
